Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Milestone Scientific, Inc. (MLSS) had Revenue of $8.97M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$8.97M
Net Income	$-5.72M
Cost of Goods Sold	$2.57M
Gross Profit	$6.41M
Operating Expenses	$14.67M
Operating Income	$-5.70M
Non-Operating Income/Expense	$-0.03M
Pre-Tax Income	$-5.72M
Normalized Pre-Tax Income	$-5.72M
Income after Taxes	$-5.72M
Income from Continuous Operations	$-5.72M
Consolidated Net Income/Loss	$-5.72M
Normalized Income after Taxes	$-5.72M
EBIT	$-5.70M
EBITDA	$-5.51M
Weighted-Average Shares Outstanding (Basic)	82.06M
Weighted-Average Shares Outstanding (Diluted)	82.06M
Earnings per Share (EPS) (Basic)	$-0.07
Earnings per Share (EPS) (Diluted)	$-0.07
Balance Sheet Financials
Current Assets	$7.48M
Property, Plant, and Equipment	$0.02M
Long-Term Assets	$0.33M
Total Assets	$7.81M
Current Liabilities	$4.13M
Long-Term Debt	$0.83M
Long-Term Liabilities	$0.86M
Total Liabilities	$4.99M
Common Equity	$2.81M
Tangible Shareholders Equity	$2.73M
Shareholders Equity	$2.81M
Common Shares Outstanding	80.45M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.92M
Cash Flow from Investing Activities	$-0.02M
Cash Flow from Financial Activities	$0.79M
Beginning Cash	$3.26M
End Cash	$1.11M
Increase/Decrease in Cash	$-2.15M
Stock-Based Compensation	$1.68M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.81
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.23
Debt to Equity Ratio	0.30
Gross Margin	71.40%
Operating Margin	-63.48%
EBIT Margin	-63.48%
EBITDA Margin	-61.41%
Pre-Tax Profit Margin	-63.76%
Profit Margin	-63.76%
Free Cash Flow	$-2.93M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.15
Inventory Turnover	0.68
Receiveable Turnover	12.71
Days Sales in Receivables	28.72
Return on Equity	-203.45%
Return on Tangible Equity	-209.33%
Return on Assets	-73.30%
Return on Investments	-157.21%
Book Value Per Share	$0.04
Free Cash Flow per Share	$-0.04
Operating Cash Flow per Share	$-0.04

Data from Zacks Investment Research, Inc.